Dr. Abria Magee is the Sr. Program Manager for Product Development Research at the Cancer Prevention and Research Institute of Texas (CPRIT). Dr. Magee manages a portfolio of over 50 oncology companies that have been awarded over $320 million in CPRIT funding. She is responsible for developing and piloting new PDR program concepts for the expansion of product development funding mechanisms. Prior to joining CPRIT, Dr. Magee was the Associate Director of Industry Ventures in the Office of Technology Transfer and Innovation at the University of Houston. There, she managed external industry partnerships and assisted faculty with industry collaborations.
Dr. Magee serves as a member of the National Institutes of Health (NIH) Interdisciplinary Molecular Sciences and Training (IMST) Integrated Review Group (IRG). For the past few years, she has peer reviewed NIH’s Small Business Technology Transfer (STTR) grant applications focused on entrepreneurship and product development.
Dr. Magee is a native Houstonian and received her doctorate degree in Plant Pathology and Microbiology from Texas A&M University in College Station, TX. During her graduate program, Dr. Magee characterized extremophilic bacteria for their potential in the biofuel and bioprocess industries. Following her graduate program, she completed a Therapeutic Microbiology Fellowship at Texas Children’s Microbiome Center (TCMC) and a postdoctoral fellowship at Baylor College of Medicine (BCM) in the department of Pathology & Immunology. Her research at the TCMC and BCM explored the use of cutting-edge sequencing technology and applying these technologies directly to patient care (e.g. gut microbiota transplants). Following her fellowship, Dr. Magee worked as a Project Manager at a BCM Technologies portfolio company that provided microbiome sequencing and analysis services.
In her spare time, Dr. Magee enjoys spending time with her husband and three sons.Sessions: